Characteristics of patients with non-variceal upper gastrointestinal bleeding taking antithrombotic agents

Digestive Endoscopy

Volumn 27, Issue 1, 2015, Pages 30-36

  Yamaguchi, Daisuke ^a   Sakata, Yasuhisa ^a   Tsuruoka, Nanae ^a   Shimoda, Ryo ^a   Higuchi, Toru ^a   Sakata, Hiroyuki ^a   Fujimoto, Kazuma ^a   Iwakiri, Ryuichi ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

anticoagulant; antiplatelet; antithrombotic; thromboembolism; upper gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CILOSTAZOL; CLOPIDOGREL; HEMOGLOBIN; ICOSAPENTAENOIC ACID; PROSTAGLANDIN DERIVATIVE; SARPOGRELATE; TICLOPIDINE; WARFARIN; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; STOMACH ULCER; UPPER GASTROINTESTINAL BLEEDING; DRUG EFFECTS; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; INCIDENCE; JAPAN; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; UPPER GASTROINTESTINAL TRACT;

AGED; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FIBRINOLYTIC AGENTS; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; UPPER GASTROINTESTINAL TRACT;

EID: 84922676502     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/den.12316     Document Type: Article

References (28)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
2. Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-830.
3. Nakayama M, Iwakiri R, Hara M, et al. Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. J. Gastroenterol. 2009; 44: 912-918.
4. Johnsen SP, Sørensen HT, Mellemkjoer L, et al. Hospitalisation for upper gastrointestinal bleeding associated with use of oral anticoagulants. Thromb. Haemost. 2001; 86: 563-568.
5. Nakamura K, Akahoshi K, Ochiai T, et al. Characteristics of hemorrhagic peptic ulcers in patients receiving antithrombotic/nonsteroidal antiinflammatory drug therapy. Gut Liver. 2012; 6: 423-426.
6. Shimizu S, Nakamura S, Kishino M, Konishi H, Shiratori K,. Role of antithrombotic therapy and nonsteroidal anti-inflammatory drug use in bleeding gastroduodenal ulcers. Intern. Med. 2009; 48: 631-637.
7. Ono S, Fujishiro M, Kanzaki H, et al. Conflicting clinical environment about the management of antithrombotic agents during the periendoscopic period in Japan. J. Gastroenterol. Hepatol. 2011; 26: 1434-1440.
8. Iwatsuka K, Gotoda T, Kusano C, et al. Clinical management of esophagogastroduodenoscopy by clinicians under the former guidelines of the Japan Gastroenterological Endoscopy Society for patients taking anticoagulant and antiplatelet medications. Gastric Cancer. Published online: 8 Jan 2014; DOI: 10.1007/s10120-013-0333-z
9. Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig. Endosc. 2014; 26: 1-14.
10. Lee SY, Tang SJ, Rockey DC, et al. Managing anticoagulation and antiplatelet medications in GI endoscopy: A survey comparing the East and the West. Gastrointest. Endosc. 2008; 67: 1076-1081.
11. Forrest JA, Finlayson ND, Shearman DJ,. Endoscopy in gastrointestinal bleeding. Lancet 1974; 2: 394-397.
12. Ootani H, Iwakiri R, Shimoda R, et al. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J. Gastroenterol. 2006; 41: 41-46.
13. Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann. Intern. Med. 1993; 118: 511-520.
14. Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O,. Clinical outcome in upper gastrointestinal bleeding complicating low-dose aspirin and antithrombotic drugs. Aliment. Pharmacol. Ther. 2006; 24: 633-636.
15. Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: Population based case-control study. BMJ 2006; 333: 726-731.
16. Suehiro T, Yakeishi Y, Sakai F, et al. Gastrointestinal bleeding and blood transfusion in the elderly in Japan. Hepatogastroenterology 2012; 59: 1480-1483.
17. Thomopoulos KC, Vagenas KA, Vagianos CE, et al. Changes in aetiology and clinical outcome of acute gastrointestinal bleeding during the last 15 years. Eur. J. Gastroenterol. Hepatol. 2004; 16: 177-182.
18. Fattahi E, Somi MH, Moosapour MR, Fouladi RF,. Independent predictors of in-hospital re-bleeding, need of operation and mortality in acute upper gastrointestinal bleeding. Pak. J. Biol. Sci. 2011; 14: 849-853.
19. Dulai GS, Gralnek IM, Oei TT, et al. Utilization of health care resources for low-risk patients with acute, nonvariceal upper GI hemorrhage: An historical cohort study. Gastrointest. Endosc. 2002; 55: 321-327.
20. Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR,. Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: Results of a nationwide audit. Gut 2010; 59: 1022-1029.
21. Yeomans ND, Lanas AI, Tally NJ, et al. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment. Pharmacol. Ther. 2005; 22: 795-801.
22. de Groot NL, van Oijen MG, Kessels K, et al. Reassessment of the predictive value of the Forrest classification for peptic ulcer rebleeding and mortality: Can classification be simplified? Endoscopy 2014; 46: 46-52.
23. Sugimoto M, Nishino M, Kodaira C, et al. Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole. J. Clin. Pharmacol. 2010; 50: 320-330.
24. Suehiro T, Yakeishi Y, Sakai F, et al. Gastrointestinal bleeding associated with antithrombotic therapy in the elderly in Japan. Hepatogastroenterology 2012; 59: 774-777.
25. Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O,. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy. Aliment. Pharmacol. Ther. 2006; 23: 489-495.
26. Furukawa N, Iwakiri R, Koyama T, et al. Proportion of reflux esophagitis in 6010 Japanese adults: Prospective evaluation by endoscopy. J. Gastroenterol. 1999; 34: 441-444.
27. Soejima H, Ogawa H, Morimoto T, et al. Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial. Circ. J. 2012; 76: 1526-1532.
28. Ono S, Fujishiro M, Kodashima S, et al. Evaluation of safety of endoscopic biopsy without cessation of antithrombotic agents in Japan. J. Gastroenterol. 2012; 47: 770-774.